filipe-frazao-shutterstock-com

Filipe Frazao / Shutterstock.com

21 May 2015Asia-Pacific

IP in Australia: major changes in store

Just two years after one of the biggest ever shake-ups to Australian patent law—the Raising the Bar Act of 2012—further change is in store for pharmaceutical and biotechnology companies operating in Australasia.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

UPC bans Meril Life Sciences from selling infringing heart valve

GSK triumphs in EPO appeal, revoking Pfizer patent

‘We took Ravgen head-on’: How we won zero-damages and others didn't

White & Case hires experienced litigator from A&O Shearman

China’s new policies on foreign investment in healthcare and biotech

Startup CFO’s betrayal is a lesson in preparing for the worst

Sanofi subsidiary fends off $450m trade secrets case

UK Budget: A missed opportunity?